Agnes H. is currently the Director of Global HTA Value & Evidence for Genitourinary Cancers. They hold a Master's Degree in Health Outcomes, Policy and Economics and are pursuing a Doctor of Pharmacy (PharmD) at Rutgers University. Previously, Agnes served in various roles at Pfizer, including Director of US Value & Evidence Oncology for ORGOVYX and Gastrointestinal Global Medical Franchise Fellow. Their experience also includes positions at Astellas Pharma and Genentech, where they focused on oncology outcomes research. Additionally, Agnes was an adjunct faculty member at Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices